Pharmacologic management of bone-related complications and bone metastases in postmenopausal women with hormone receptor-positive breast cancer
Denise A Yardley1,2 1Sarah Cannon Research Institute, Nashville, TN, USA; 2Tennessee Oncology, Nashville, TN, USA Abstract: There is a high risk for bone loss and skeletal-related events, including bone metastases, in postmenopausal women with hormone receptor-positive breast cancer. Both the disea...
Guardado en:
Autor principal: | Yardley DA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/269af8026fbc43f1ab786efcbd6a69cf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Management of bone metastases in refractory prostate cancer – role of denosumab
por: Paller CJ, et al.
Publicado: (2012) -
Regulation of the Bone Healing Process by Hormones
por: Issa,Joáo Paulo Mardegan, et al.
Publicado: (2007) -
Surgical treatment for pelvic bone metastases
por: Artem V. Buharov, et al.
Publicado: (2021) -
PI3Kinase Inhibition in Hormone Receptor-Positive Breast Cancer
por: Ajay Dhakal, et al.
Publicado: (2021) -
68Ga-P15-041, A Novel Bone Imaging Agent for Diagnosis of Bone Metastases
por: Rui Guo, et al.
Publicado: (2021)